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National Enteric Disease Surveillance:
COVIS Annual Summary, 2013
Summary of Human Vibrio Cases Reported to CDC, 2013
The Cholera and Other Vibrio Illness Surveillance (COVIS) system is a national surveillance system for human 
infection with pathogenic species of the family Vibrionaceae, which cause vibriosis and cholera. The Centers 
for Disease Control and Prevention (CDC) maintains COVIS. Information from COVIS helps track Vibrio infections 
and determine host, food, and environmental risk factors for these infections.
CDC initiated COVIS in collaboration with the Food and Drug Administration and four Gulf Coast states 
(Alabama, Florida, Louisiana, and Texas) in 1989. Using the COVIS report form (available at http://www.cdc.gov/
nationalsurveillance/PDFs/CDC5279_COVISvibriosis.pdf ), participating health officials report cases of vibriosis 
and cholera. The case report includes clinical data, including information about underlying illness; detailed history 
of seafood consumption; detailed history of exposure to bodies of water, raw or live seafood or their drippings, 
or contact with marine life in the seven days before illness onset; and traceback information on implicated seafood.
Before 2007, only cholera, which by definition is caused by infection with toxigenic Vibrio cholerae serogroup O1 
or O139, was nationally notifiable. In January 2007, infection with other serogroups of V. cholerae and other 
species from the family Vibrionaceae also became nationally notifiable, as vibriosis.
CDC requests that all state health departments send all Vibrio cholerae and Vibrio mimicus isolates to CDC for 
additional characterization. For V. cholerae, CDC identifies serogroups O1, O75, O139, and O141 and determines 
whether the isolate produces cholera toxin. For all Vibrio species (excluding V. cholerae), CDC accepts isolates 
for antimicrobial resistance testing and all outbreak isolates for identification. Although all Vibrio infections are 
nationally notifiable, many cases are likely not recognized because Vibrios are not easily identified on routine 
enteric media. A selective medium, such as thiosulfate citrate bile salts sucrose agar (TCBS), should be used.
This report summarizes human Vibrio infections occurring during 2013 reported to COVIS. Results are presented 
in two categories: (1) infection with pathogenic species of the family Vibrionaceae (other than toxigenic Vibrio 
cholerae serogroups O1 and O139), which cause vibriosis; this category includes infection with toxigenic V. 
cholerae of serogroups other than O1 and O139, and (2) infection with toxigenic V. cholerae serogroups O1 and 
O139, which cause cholera. While many Vibrio species are well-recognized human pathogens, the status of some 
species (including Photobacterium damselae subsp. damselae (formerly V. damsela), V. furnissii, V. metschnikovii, and 
V. cincinnatiensis) as human enteric or wound pathogens is less clear.
Understanding the routes by which infection is transmitted is essential for control. For vibriosis, cases are 
summarized by place of exposure (travel-associated vs. domestically acquired). Travel-associated cases are 
defined as infections in persons who reported international travel in the seven days before illness began; all other 
infections were defined as domestically-acquired cases. For domestically acquired vibriosis, transmission routes 
(foodborne, non-foodborne, and unknown) are determined based on reported patient exposures and specimen 
sites (see Appendix for classification method). For toxigenic V. cholerae (all serogroups), exposures are summarized 
by place of exposure (travel-associated vs. domestically acquired) and then, if information is available, by source 
(such as consumption of contaminated seafood).
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I. Vibriosis
Pathogenic species of the family Vibrionaceae (excluding toxigenic V. cholerae O1 and O139)
In 2013, 1,176 Vibrio infections (excluding toxigenic V. cholerae O1 and O139) were reported to COVIS (Table 1). 
Among patients for whom information was available, 363 (35%) of 1,041 were hospitalized, and 43 (4%) 
of 1,042 died. The most frequently reported species was V. parahaemolyticus, which was isolated from 594 (51%) 
of patients. Of the patients infected with V. parahaemolyticus for whom information was available, 112 (21%) 
of 543 were hospitalized, and 4 (<1%) of 546 died. V. alginolyticus was isolated from 208 (18%) of the patients; 
of the patients for whom information was available, 37 (23%) of 137 were hospitalized; one death was reported. 
V. vulnificus was isolated from 137 (12%) of the patients; of the patients for whom information was available, 
120 (94%) of 127 were hospitalized, and 32 (28%) of 115 died.
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Geographic Location
Of the 1,176 vibriosis cases, 340 (29%) were reported from Gulf Coast states, 276 (23%) from Pacific Coast states, 424 
(36%) from Atlantic Coast states, and 136 (12%) from non-coastal states (Figure 1).
The Vibrio species reported most frequently from Gulf Coast states were V. vulnificus 87 (26%), V. parahaemolyticus 83 
(24%), and V. alginolyticus 81(24%). The Vibrio species reported most frequently from non-Gulf Coast states were V. 
parahaemolyticus 511 (61%), V. alginolyticus 127 (15%), and V. vulnificus 50 (6%).
Figure 1. Number of cases of Vibrio infections (excluding toxigenic V. cholerae O1 and O139), by state, 2013 
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Transmission categories and reported exposures
Among the 1,176 vibriosis patients, 60 (5%) reported international travel in the seven days before illness began. 
Among the 1,116 domestically-acquired vibriosis cases, 644 (58%) were classified as confirmed or probable 
foodborne, 353 (32%) as confirmed or probable non-foodborne, and 119 (11%) as having an unknown transmission 
route (Figure 2). Illnesses peaked in the summer months for all categories, but the peak was most pronounced for 
foodborne infections (Figure 3).
Among the 290 patients with confirmed and probable foodborne vibriosis who reported eating a single seafood item 
(Table 2), 169 (58%) ate oysters (88% of whom consumed them raw), 26 (9%) ate clams (81% of whom consumed 
them raw), 18 (6%) ate crab, and 14 (5%) ate finfish.
For cases with non-foodborne transmission, 298 (84%) patients reported having skin exposure to a body of water 
within 7 days before illness began, 65 (18%) reported contact with marine wildlife, and 46 (5%) reported handling 
seafood.
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Figure 2.  Domestically acquired vibriosis cases by transmission route and species, United States, 
United States, 2013 (N=1,116).
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Figure 3.  Domestically acquired vibriosis cases, by month of illness onset or specimen collection 
(when onset date not available), and transmission route, United States, 2013 (N=1,115).
*1 unknown transmission case missing onset and specimen collection dates.
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Table 2.  Seafood exposures among 290 patients with domestically-acquired foodborne vibriosis who reported 
eating a single seafood item in the week before illness onset, United States, 2013.
* Other shellfish reported: conch and scallops. 
† Finfish reported: catfish, cod, eel, haddock, halibut, red snapper, salmon, sardines, and tilapia. 
Mollusks Crustaceans Other







n (% of 290)
169 (58) 26 (9) 0 (0) 10 (3) 4 (1) 18 (6) 3 (1) 3 (1) 14 (5)
Patients who 
ate the single 
seafood item 
raw, n (% of n in 
row above)
148 (88) 21 (81) 0 (0) 1 (10) 0 (0) 4 (22) 0 (0) 1 (33) 2 (14)
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Laboratory
In 2013, CDC confirmed 279 isolates as V. parahaemolyticus; eight serogroups were identified: O4 (51%), O1 (18%), 
O11 (11%), O5 (9%), O3 (5%), O10 (5%), O8 (2%), and O6 (1 isolate, <1%). Among the serogroup O4 isolates, 118 (42%) 
were K4 and 20 (7%) were Kunknown.
Toxigenic V. cholerae, excluding serogroups O1 and O139
Serogroup O141
In 2013, no patients with toxigenic V. cholerae serogroup O141 infection were reported.
Serogroup O75
In 2013, one patient with toxigenic V. cholerae O75 infection was reported. The patient reported consuming cooked 
blue crab that was purchased from a seafood market. Harvest area is unknown.














Susceptible to all 
drugs tested in V. 
cholerae panel
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II. Cholera
Serogroups O1 & O139
In 2013, 14 patients with toxigenic V. cholerae serogroup O1 infection were reported. Of the 14 patients, 73% were 
hospitalized and none died. Thirteen (93%) cases were travel-associated (8 with travel to Haiti, 1 to the Dominican 
Republic, 2 to Cuba, and 2 to other cholera-affected countries). The remaining patient reported no travel; however, 
this patient was a healthcare worker who reported caring for a cholera patient in the hospital.
No cases of toxigenic V. cholerae O139 infection were reported.
Table 4. Cases of toxigenic V. cholerae serogroup O1, biotype El Tor, infection, 2013.
*FUR=furazolidone, NAL=nalidixic acid, SOX=sulfisoxazole, STR=streptomycin, STX=trimethoprim-sulfamethoxazole
Location Age Sex




Exposure Serotype Antimicrobial Resistance* 
Massachusetts 39 M January Yes Travel to Haiti Ogawa FUR, NAL, SOX, STR, STX
Delaware 57 F January Yes Travel to Haiti Ogawa FUR, NAL, SOX, STR, STX
Connecticut 57 M January Yes Travel to Haiti Ogawa FUR, NAL, SOX, STR, STX
Massachusetts 78 F February Yes Travel to Dominican Republic Ogawa FUR, NAL, SOX, STR, STX
Florida 46 F July Yes Travel to Haiti Ogawa FUR, NAL, SOX, STR, STX
Florida 51 F July Yes Travel to Haiti Ogawa FUR, NAL, SOX, STR, STX
Florida 80 F July Yes No travel Ogawa FUR, NAL, SOX, STR, STX
Washington 47 F August Yes Travel to Haiti Ogawa FUR, NAL, SOX, STR, STX
Massachusetts 65 F August Yes Haiti of resident Ogawa FUR, NAL, SOX, STR, STX
Minnesota 57 F August Yes Travel to India Ogawa FUR, NAL, SOX, STR, STX
Florida 58 M September Yes Travel to Haiti Ogawa FUR, NAL, SOX, STR, STX
Illinois 87 M October Yes Travel to Cuba Ogawa FUR
Florida 49 M December Yes Travel to Cuba Ogawa FUR, NAL, SOX, STR, STX
New Jersey 51 M December Yes Travel to China, Philippines, 
Bahrain, Cyprus
Ogawa FUR, NAL, SOX, STR, STX
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Appendix
Method for Classification of Transmission Routes in the Cholera and Other Vibrio Illness Surveillance 
(COVIS) System
I. Exposure categories
To classify transmission routes, the first step is to categorize patient exposures. For a given illness episode, >1 patient 
exposure can be reported to COVIS; each reported exposure is categorized individually. If all exposures fall into 
a single category, then the report is considered to have a single exposure category. If not, the report is considered 
to have multiple exposure categories. For a given case, if any exposure is reported, we assume that other exposures 
for which information was not reported were not present. Exposures are classified using three categories:
1. Seafood consumption: Ingestion of seafood. Does not include touching seafood.
2.  Marine/estuarine contact: Includes direct skin contact with marine/estuarine life, bodies of water, or drippings 
from raw or live seafood.
3. Unknown exposure: no exposure history reported.
II. Specimen site categories
The next step in classifying transmission routes is to categorize reported specimen sites. For a given illness episode, 
>1 specimen site can be reported; each reported site is categorized individually. If all specimen sites fall into a single 
category, then the report is considered to have a single specimen site category. If not, then the report is considered 
to have multiple specimen site categories. Specimen sites are classified using five categories:
1. Gastrointestinal site (GI): stool, bile, appendix, rectum, gall bladder, colon
2.  Blood or other normally sterile site (sterile): blood, cerebrospinal fluid (CSF), peritoneal fluid, lumbar disc fluid, 
lymph node, bullae
3.  Skin or soft tissue site (SST): wound, ear (other than otitis media and middle ear, which are included in ‘other, 
non-sterile site’), appendage, tissue
4.  Other, non-sterile site (ONS): urine, sputum, aspirate, bronchial washing, effusion, catheter, endotracheal, 
eye, nasal, placenta, respiratory, sinus, tonsil
5. Unknown site (unknown): no specimen site reported or no site specified for ‘other’
Note:  The lists of sites for each category above are not intended to be exhaustive. Rather, they reflect the sites 
actually reported to COVIS and can be updated if new sites are reported.
III. Transmission route
The final step in classifying transmission involves review of exposure and specimen site categories for each reported 
case. Reports are classified into one of three transmission routes, foodborne, non-foodborne, and unknown, based 
on criteria below:
1. Single exposure category: seafood consumption
 •  Confirmed Foodborne: Vibrio isolated only from GI or sterile site OR Vibrio isolated from multiple specimen site 
categories, including a GI site.
 •  Probable Foodborne: Vibrio isolated only from SST, ONS, or unknown sites OR Vibrio isolated from multiple 
specimen site categories, not including GI.
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2. Single exposure category: marine/estuarine contact
 •  Confirmed Non-foodborne: Vibrio isolated only from SST or sterile site OR Vibrio isolated from multiple 
specimen site categories, with SST reported.
 •  Probable Non-foodborne: Vibrio isolated only from GI, ONS, or unknown sites OR Vibrio isolated from multiple 
specimen site categories, not including SST.
3. Multiple exposure categories: both seafood consumption AND marine/estuarine contact
 •  Confirmed Foodborne: Vibrio isolated only from a GI site OR Vibrio isolated from multiple specimen site 
categories, with GI reported and SST not reported
 •  Confirmed Non-foodborne: Vibrio isolated only from a SST site OR Vibrio isolated from multiple specimen site 
categories, with SST reported and GI not reported
 •  Unknown: Vibrio isolated only from a sterile, ONS, or unknown site OR Vibrio isolated from multiple specimen 
site categories, including either 1) both GI and SST or 2) neither GI nor SST.
4.  Unknown or no reported exposure (note that categorization is the same as for multiple exposure 
categories)
 •  Confirmed Foodborne: Vibrio isolated only from a GI site OR Vibrio isolated from multiple specimen site 
categories, with GI reported and SST not reported
 •  Confirmed Non-foodborne: Vibrio isolated only from a SST site OR Vibrio isolated from multiple specimen site 
categories, with SST reported and GI not reported
 •  Unknown: Vibrio isolated only from a sterile, ONS, or unknown site OR Vibrio isolated from multiple specimen 
site categories, including either 1) both GI and SST or 2) neither GI nor SST.
NCEZID Atlanta: 
For more information please contact Centers for Disease Control and Prevention 
1600 Clifton Road NE, Atlanta, GA 30333 MS C-09 
Telephone: 1-404-639-2206  
Email: cdcinfo@cdc.gov
